RB
Robert Burns HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
128
Avg Return
Past Year
Past Year
30%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.2%
Neutral
8.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $14 |
77%
upside
| 3 | +34% |
0
%
| 26 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $40 |
121%
upside
| 4 | +16% |
0
%
| 22 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $42 |
104%
upside
| 5 | -2.7% |
0
%
| 12 Aug ‘25 5 months ago |
|
|
|
Buy
Maintained
| $10 |
251%
upside
| 2 | +29% |
0
%
| 11 Aug ‘25 5 months ago |
|
|
|
Neutral
Downgraded
| $8.60 | – | 4 | +21% |
0
%
| 6 Aug ‘25 5 months ago |
|
|
|
Buy
Maintained
| $10 |
221%
upside
| 3 | -5% |
0
%
| 6 Aug ‘25 5 months ago |
|
|
|
Buy
Maintained
| $13 |
61%
upside
| 2 | +36% |
0
%
| 17 Jul ‘25 5 months ago |
|
|
|
Buy
Maintained
| $48 |
77%
upside
| 3 | +11% |
0
%
| 2 Jul ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $47 |
0%
upside
| 4 | -4.9% |
0
%
| 30 Apr ‘25 8 months ago |
|
|
|
Buy
Reiterated
| $13 |
14%
upside
| 1 | +707% |
0
%
| 14 Apr ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $5 |
320%
upside
| 1 | -7% |
0
%
| 20 Mar ‘25 9 months ago |
|
|
|
Buy
Maintained
| $8 |
355%
upside
| 1 | +5.3% |
0
%
| 19 Mar ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | -22% |
–
| 30 Jan ‘25 11 months ago |
|
|
|
Neutral
Reiterated
| – | – | 2 | – |
–
| 28 Jan ‘25 11 months ago |
|